$MAJI - is expecting to receive new data from its Glio study being conducted at UCF any day. Once we review the data, Dr. Hausman will update the Orphan Drug Application and submit it to the FDA. We will release new research exosomes to the market in June, and an update on our acquisition target will come shortly.
$MAJI - is expecting to receive new data from its Glio study being conducted at UCF any day. Once we review the data, Dr. Hausman will update the Orphan Drug Application and submit it to the FDA. We will release new research exosomes to the market in June, and an update on our…
— NextTel Medical Corp (@NexTelMedical) May 16, 2025
Market Data 
Markets 
AI
